Page last updated: 2024-10-30

mazindol and Psychotic Disorders

mazindol has been researched along with Psychotic Disorders in 1 studies

Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpenter, WT1
Breier, A1
Buchanan, RW1
Kirkpatrick, B1
Shepard, P1
Weiner, E1

Trials

1 trial available for mazindol and Psychotic Disorders

ArticleYear
Mazindol treatment of negative symptoms.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:4

    Topics: Adult; Analysis of Variance; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Fe

2000